Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD206 inhibitors(Macrophage mannose receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Belgium | 30 Mar 2023 | |
Atherosclerosis | Phase 2 | Belgium | 26 Jan 2021 | |
Cardiac sarcoidosis | Phase 2 | Belgium | 26 Jan 2021 | |
Carotid Stenosis | Phase 2 | Belgium | 26 Jan 2021 | |
Head and Neck Neoplasms | Phase 2 | Belgium | 26 Jan 2021 | |
Hodgkin's Lymphoma | Phase 2 | Belgium | 26 Jan 2021 | |
Lymphohistiocytosis, Hemophagocytic | Phase 2 | Belgium | 26 Jan 2021 | |
Non-Hodgkin Lymphoma | Phase 2 | Belgium | 26 Jan 2021 | |
Hormone receptor negative HER2 positive breast cancer | Phase 2 | Belgium | 05 Nov 2019 | |
Locally Advanced Malignant Solid Neoplasm | Phase 2 | Belgium | 05 Nov 2019 |